LIFEVANTAGE CORP Shareholders' Equity
LIFEVANTAGE CORP (LFVN) had Shareholders' Equity of $33.59 million as of 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-27
- 2026-06-30: Stockholders' Equity Attributable to Parent $33.59M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $33.34M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $32.99M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $33.16M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $33.59M 10-K · filed 2026-08-27 | |
| 2026-03-31 | $33.34M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $32.99M 10-Q · filed 2026-05-06 | |
| 2025-09-30 | $33.16M 10-Q · filed 2026-05-06 | |
| 2025-06-30 | $34.64M 10-K · filed 2026-08-27 | |
| 2025-03-31 | $34.01M 10-Q · filed 2026-05-06 | |
| 2024-12-31 | $29.89M 10-Q · filed 2026-05-06 | |
| 2024-09-30 | $27.70M 10-Q · filed 2026-05-06 | |
| 2024-06-30 | $25.99M 10-K · filed 2026-08-27 | |
| 2024-03-31 | $26.77M 10-Q · filed 2025-05-06 | |
| 2023-12-31 | $27.31M 10-Q · filed 2025-05-06 | |
| 2023-09-30 | $29.29M 10-Q · filed 2025-05-06 | |
| 2023-06-30 | $34.65M 10-K · filed 2025-09-04 | |
| 2023-03-31 | $33.44M 10-Q · filed 2024-05-02 | |
| 2022-12-31 | $31.89M 10-Q · filed 2024-05-02 | |
| 2022-09-30 | $31.89M 10-Q · filed 2024-05-02 | |
| 2022-06-30 | $31.52M 10-K · filed 2024-08-28 | |
| 2022-03-31 | $34.03M 10-Q · filed 2023-05-04 | |
| 2021-12-31 | $34.78M 10-Q · filed 2023-05-04 | |
| 2021-09-30 | $37.31M 10-Q · filed 2023-05-04 | |
| 2021-06-30 | $36.81M 10-K · filed 2023-08-28 | |
| 2021-03-31 | $35.63M 10-Q · filed 2022-05-03 | |
| 2020-12-31 | $35.52M 10-Q · filed 2022-05-03 | |
| 2020-09-30 | $34.14M 10-Q · filed 2022-05-03 | |
| 2020-06-30 | $33.25M 10-K · filed 2022-08-23 | |
| 2020-03-31 | $28.60M 10-Q · filed 2021-04-29 | |
| 2019-12-31 | $29.10M 10-Q · filed 2021-04-29 | |
| 2019-09-30 | $29.62M 10-Q · filed 2021-04-29 | |
| 2019-06-30 | $27.20M 10-K · filed 2022-08-23 | |
| 2019-03-31 | $24.75M 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $21.02M 10-Q · filed 2019-05-01 | |
| 2018-09-30 | $23.53M 10-Q · filed 2019-05-01 | |
| 2018-07-01 | $21.94M 10-K · filed 2019-08-14 | |
| 2018-06-30 | $21.95M 10-K · filed 2021-08-19 | |
| 2018-03-31 | $19.30M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $16.50M 10-Q · filed 2018-02-07 | |
| 2017-09-30 | $15.77M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $14.53M 10-K · filed 2020-08-18 | |
| 2017-03-31 | $13.89M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $14.51M 10-Q · filed 2017-02-08 | |
| 2016-09-30 | $14.08M 10-Q · filed 2016-12-12 | |
| 2016-06-30 | $10.65M 10-K · filed 2019-08-14 | $12.13M 10-K · filed 2016-12-12 |
| 2016-03-31 | $8.84M 10-Q/A · filed 2016-07-19 | |
| 2015-12-31 | $7.01M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $4.58M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $1.81M 10-K · filed 2018-08-15 | $3.33M 10-K · filed 2015-09-01 |
| 2015-03-31 | $2.83M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $4.55M 10-Q · filed 2015-02-04 | |
| 2014-09-30 | $7.20M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $2.33M 10-K · filed 2017-09-07 | $3.99M 10-K · filed 2014-09-10 |
| 2014-03-31 | $2.73M 10-Q · filed 2014-05-06 | |
| 2013-12-31 | -$548.00K 10-Q · filed 2014-02-06 | |
| 2013-09-30 | $35.08M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $33.95M 10-K · filed 2016-12-12 | |
| 2013-03-31 | $34.86M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $35.03M 10-Q · filed 2013-02-07 | |
| 2012-09-30 | $34.12M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $28.28M 10-K · filed 2015-09-01 | $28.28M 10-K · filed 2012-09-10 |
| 2012-03-31 | $22.53M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $9.33M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | -$16.20M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$20.81M 10-K · filed 2014-09-10 | -$20.81M 10-Q · filed 2011-11-14 |
| 2010-06-30 | -$16.18M 10-K · filed 2013-09-12 | -$16.17M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |